Hesai is the global unit-volume and revenue leader in automotive LiDAR — Yole Group's independent "Lidar for Automotive 2025" report credits it with 33% of global automotive LiDAR revenue and, in its 2025 update, 43% of the long-range ADAS passenger-car volume segment, a position held for four consecutive years. It is also the industry's only company covered in this report with a real, sustained GAAP profit record: Q2 2026 marked its fifth consecutive profitable quarter (net income RMB70.6 million on RMB860.8 million revenue, +21.9% YoY), and LiDAR unit shipments rose ~80% YoY to over 628,000 units. Manufacturing scale is real and disclosed, not aspirational: the "Maxwell" facility in Shanghai runs at ~90% automation with a ~45-second cycle time and a planned capacity above one million units a year, and Hesai has since announced a Bangkok, Thailand plant aimed at demand outside China. Named OEM design wins in the reporting window include Toyota and a second "top European OEM" 1-million-unit order across 10+ models (May 2026), alongside existing relationships with Li Auto, Neta Auto and a roster of robotaxi operators (Zoox, Aurora, Apollo/Baidu, Didi, Pony.ai, WeRide) that gives Hesai a reported 61% share of the robotaxi LiDAR segment specifically.
None of this is priced as a secret: at a trailing P/E of 36.99x (CMP $17.10, 22 Sep 2026), the market is already paying a full multiple for a profitable, ~20-40%-revenue-growth China-based sensor company. Twenty sell-side analysts carry an average "Strong Buy" rating and a $28.29 target, implying roughly 65% upside from the current price — a gap this report's own, more conservative arithmetic (below) does not fully close, because it weights a real, unresolved risk the consensus view may be under-pricing: Hesai remains tangled in an active, unresolved US Department of Defense "Chinese Military Company" (Section 1260H) listing dispute. DoD added Hesai in January 2024, removed it in August 2024, then moved to relist it; a district court upheld the relisting, and in August 2026 the D.C. Circuit Court of Appeals reversed that ruling and remanded the matter, ordering DoD to cure procedural defects — leaving Hesai's ultimate designation status genuinely unresolved as of this report's research date, and, per Bloomberg reporting (22 Sep 2026), a live irritant in broader US-China trade diplomacy.
The business quality is not in question. Gross margin did compress slightly YoY (40.1% vs 42.5% in Q2 2026) on mix shift toward higher-volume, lower-margin product, which is worth watching but is not yet a red flag on a company still growing shipments 80% YoY. Balance-sheet strength is real: ~RMB7.05 billion (~US$1.04 billion) in cash and investments against just RMB637.5 million of debt, a comfortably net-cash position. The open item this report could not close — a share-count reconciliation between the ~1.25-1.3 billion "ordinary shares" figure in Hesai's own 6-K and the ~156.44 million "ADS-equivalent" share count used by market-data aggregators for per-share metrics — means every per-share and market-cap figure below should be read as sourced from the aggregator convention, not independently rebuilt from the primary filing's own share count.
Net: HOLD. This is the highest-quality business in this report's coverage universe, but not, on this report's own arithmetic, a mispriced one — the current multiple already reflects the growth and profitability story, and a prudent risk-adjusted view keeps the target close to, not meaningfully above, the current price until the 1260H matter is actually resolved.
Hesai is a Cayman Islands holding company (Shanghai Hesai as a direct, wholly-owned operating subsidiary — a conventional equity-ownership structure, not a VIE) whose ADSs trade on Nasdaq under the full US foreign-private-issuer disclosure regime (Form 20-F annual reports, Form 6-K current reports), and which also completed a dual-primary Hong Kong listing (~$614 million offering) subject to HKEX rules in parallel. As a China-domiciled issuer, Hesai is also directly subject to Holding Foreign Companies Accountable Act (HFCAA) audit-inspection requirements.
Sustained, disclosed GAAP profitability across five consecutive quarters is itself a governance-adjacent signal of disciplined execution rare in this sector. The company's auditor, Deloitte China, has operated under PCAOB's expanded China/Hong Kong inspection access secured in December 2022, a meaningfully improved disclosure environment versus the pre-2022 period. Hesai holds the largest published LiDAR patent portfolio in the industry (~1,800 patents/applications as of Dec 2024), a genuine, verifiable IP asset.
Hesai's Class A/Class B dual-class structure concentrates ~76% of voting power with the three founders against a ~25% economic stake — a standard but real minority-shareholder-influence limitation. A related- party supply agreement with "Sharpa" had its annual cap raised from RMB100 million to RMB300 million at an August 2026 Extraordinary General Meeting — a disclosed, shareholder-approved change, but one worth tracking for scale relative to total procurement. Ownership-percentage figures conflict materially across data aggregators, likely reflecting different treatment of ADS float versus total ordinary shares including founder-held Class A stock; this report could not reconcile the two pictures against a primary Schedule 13D/G filing.
None confirmed as adjudicated misconduct, but the Section 1260H matter is a serious, live, unresolved regulatory/political designation dispute — not adjudicated wrongdoing, but a real overhang this report treats as material rather than cosmetic. The 2023 IPO-related securities class action and the 2025 short-seller-driven investigations by plaintiffs' firms are active reputational and litigation risks; no confirmed SEC enforcement action was found in this research, which is itself a limit of available public search tools rather than an affirmative clean bill.
The D.C. Circuit's remand and DoD's response on the 1260H designation; confirmation of PCAOB inspection status for Hesai's specific Deloitte China audit engagement; reconciliation of the ordinary-share vs. ADS-equivalent share count against a primary filing; resolution of the conflicting ownership/short-interest figures; and whether tariff or export-control measures specifically target Hesai's US-bound hardware given its Bangkok manufacturing hedge.
Fundamentally sound, with one real, unresolved, binary political risk the discount rate should carry explicitly. Nothing in this research points to actual misconduct, and disclosure quality and profitability are genuinely strong for the sector — but the Section 1260H matter is not a footnote, it is an active legal proceeding whose outcome could move the stock sharply in either direction, and this report's HOLD rating (rather than a valuation-supported BUY) reflects that risk being carried in the price target, not dismissed.
We anchor this valuation on Hesai's disclosed trailing P/E (CMP $17.10 ÷ 36.99x = TTM EPS of $0.4623, 22 Sep 2026, stockanalysis.com) rather than reconstructing EPS from Hesai's own, materially different ordinary-share count, because the ADS-equivalent share base is the one market-data providers — and this report's per-share arithmetic — actually use. Rather than assume "no change" as a base case, we apply a modest, deliberate discount to the current 36.99x multiple to price in the unresolved Section 1260H risk explicitly, consistent with this report's approach of showing the arithmetic in the open:
| Scenario | Target P/E (trailing) | TTM EPS ($) | Target price | Upside/(downside) |
|---|---|---|---|---|
| Bear — unfavourable 1260H resolution | 22.0x | 0.4623 | 10.17 | (40.5)% |
| Base — status quo, risk-discounted | 36.0x | 0.4623 | 16.64 | (2.7)% |
| Bull — favourable 1260H resolution | 46.0x | 0.4623 | 21.27 | +24.4% |
Base case rounded to $16.65. The 20-analyst Street consensus target of $28.29 (Strong Buy average, stockanalysis.com, 22 Sep 2026) implies a ~61x multiple on this same TTM EPS base — materially richer than this report's own bull case, and, in this report's judgement, more consistent with a best-case 1260H outcome being treated as the base case rather than one tail of a genuine range. We flag the gap rather than silently adopt either number.
Upgrade triggers: a favourable, final resolution of the Section 1260H designation; confirmed PCAOB inspection completion for Hesai's specific Deloitte China audit engagement; gross-margin stabilisation above 40% for two consecutive quarters. Downgrade triggers: DoD relisting Hesai under Section 1260H following the D.C. Circuit remand; a new US tariff or export-control action specifically targeting Chinese LiDAR hardware; gross margin falling materially below 38% on continued mix shift.
| FY2024 | FY2025 | Q2 2025 | Q2 2026 | |
|---|---|---|---|---|
| Revenue (RMB mn) | — | 3,027.6 | 706.4 | 860.8 |
| Gross margin | 42.6% | 41.8% | 42.5% | 40.1% |
| Net income (RMB mn) | — | 435.9 | 44.1 | 70.6 |
| Selected metrics | Latest |
|---|---|
| LiDAR unit shipments (Q2 2026) | 628,000+ (+~80% YoY) |
| Cash + ST + LT investments | RMB7,050.6mn (~$1.04bn) |
| Total debt | RMB637.5mn |
| Q3 2026 guidance (revenue) | RMB1,100-1,150mn |
| Global automotive LiDAR share | 33% (Yole Group, 2025) |
Source: Hesai Group Q2 2026 Form 6-K (SEC EDGAR, filed 18 Aug 2026), FY2025 Form 20-F (filed 24 Apr 2026), stockanalysis.com (market data, 22 Sep 2026), Yole Group "Lidar for Automotive 2025" as reported via Hesai's own press release and independent trade coverage.
Dart Consultants is a market intelligence and technology service provider, not a SEC-registered Investment Adviser or FINRA-registered Broker-Dealer. This report is educational material only — not investment advice, and not a recommendation to buy or sell any stock. The HOLD rating above is an educational device for summarising public information, not a regulated recommendation. The analyst(s) hold no position in, and have no banking, advisory or brokerage relationship with, Hesai Group, and have received no compensation from the company.
| 12-month target | $16.65 |
| CMP (22 Sep 2026) | $17.10 |
| Implied upside | (2.6)% |
| Rating | HOLD |
| Market cap | ~$2.68bn |
| P/E (trailing) | 36.99x |
| 52-week range | $14.29–$30.85 |
| Analyst consensus | Strong Buy, $28.29 tgt |
| Auditor | Deloitte China |
| Founder voting power | ~76% (dual-class) |
| Founder economic stake | ~25% |
| Institutional (approx.) | 37-45%* |
| Q2 25 | Q2 26 | |
|---|---|---|
| Revenue | 706.4 | 860.8 |
| Gross margin | 42.5% | 40.1% |
| Net income | 44.1 | 70.6 |
*Sources disagree (45% vs 37.4%) on different bases — see Governance.